COSCIENS Biopharma Inc. (CSCIF) stock
CSCIFOTCPerfumes, Cosmetics & Other Toilet PreparationsFiscal year ends December 31
$6.49+0.00 (0.00%)
Close on Oct 19, 2026Market cap $24.10MP/E –Yield –
COSCIENS Biopharma gross margin
Gross margin is gross profit as a percentage of revenue.
COSCIENS Biopharma's gross margin for the twelve months ending Mar 31, 2026 was 38.0%. For fiscal 2025 it was 35.3%, against 49.3% the year before. The highest annual figure on record is 100.0% in fiscal 2016.
Annual gross margin
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 35.3% | −14.0 |
| FY2024 | Dec 31, 2024 | 49.3% | +8.2 |
| FY2023 | Dec 31, 2023 | 41.1% | −17.6 |
| FY2022 | Dec 31, 2022 | 58.7% | −39.6 |
| FY2021 | Dec 31, 2021 | 98.3% | +61.7 |
| FY2020 | Dec 31, 2020 | 36.6% | +13.6 |
| FY2019 | Dec 31, 2019 | 22.9% | −69.2 |
| FY2018 | Dec 31, 2018 | 92.2% | −7.8 |
| FY2017 | Dec 31, 2017 | 100.0% | +0.0 |
| FY2016 | Dec 31, 2016 | 100.0% | – |
Quarterly gross margin
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| Q1 FY2026 | Mar 31, 2026 | 42.0% | +15.4 |
| Q4 FY2025 | Dec 31, 2025 | 34.5% | −27.2 |
| Q3 FY2025 | Sep 30, 2025 | 41.9% | −9.3 |
| Q2 FY2025 | Jun 30, 2025 | 35.4% | +0.4 |
| Q1 FY2025 | Mar 31, 2025 | 26.6% | −17.3 |
| Q4 FY2024 | Dec 31, 2024 | 61.7% | +49.5 |
| Q3 FY2024 | Sep 30, 2024 | 51.1% | +9.9 |
| Q2 FY2024 | Jun 30, 2024 | 35.0% | −22.2 |
| Q1 FY2024 | Mar 31, 2024 | 43.9% | −55.3 |
| Q4 FY2023 | Dec 31, 2023 | 12.2% | −36.0 |
| Q3 FY2023 | Sep 30, 2023 | 41.2% | −58.0 |
| Q2 FY2023 | Jun 30, 2023 | 57.3% | −37.5 |
| Q1 FY2023 | Mar 31, 2023 | 99.2% | +1.1 |
| Q4 FY2022 | Dec 31, 2022 | 48.2% | −48.8 |
| Q3 FY2022 | Sep 30, 2022 | 99.2% | +0.0 |
| Q1 FY2022 | Mar 31, 2022 | 94.8% | −3.5 |
| Q4 FY2021 | Dec 31, 2021 | 98.1% | +57.7 |
| Q3 FY2021 | Sep 30, 2021 | 97.1% | +22.8 |
| Q2 FY2021 | Jun 30, 2021 | 99.2% | +16.9 |
| Q1 FY2021 | Mar 31, 2021 | 98.3% | +77.3 |
| Q4 FY2020 | Dec 31, 2020 | 40.4% | +1657.1 |
| Q3 FY2020 | Sep 30, 2020 | 74.2% | −25.8 |
| Q2 FY2020 | Jun 30, 2020 | 82.4% | +34.4 |
| Q1 FY2020 | Mar 31, 2020 | 20.9% | +22.4 |
| Q4 FY2019 | Dec 31, 2019 | -1616.7% | −1642.2 |
| Q3 FY2019 | Sep 30, 2019 | 100.0% | +117.3 |
| Q2 FY2019 | Jun 30, 2019 | 47.9% | – |
| Q4 FY2018 | Dec 31, 2018 | -1.5% | – |
| Q3 FY2018 | Sep 30, 2018 | 25.5% | – |
| Q2 FY2018 | Jun 30, 2018 | -17.3% | – |
See a number that looks wrong?